期刊
FRONTIERS IN BIOSCIENCE-LANDMARK
卷 9, 期 -, 页码 975-994出版社
FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/1289
关键词
disease; infection; microorganisms; bacterium; mycobacterium tuberculosis; anti-tuberculosis drugs; mechanisms of resistance; tuberculosis; review
资金
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007608, R01AI049485, R01AI044063] Funding Source: NIH RePORTER
- NIAID NIH HHS [AI49485, AI44063, T32 AI07608] Funding Source: Medline
Tuberculosis is a worldwide health problem posing increasing threat with the spread of HIV infection and drug resistant Mycobacterium tuberculosis strains. Consequently, control of this disease has become a significant challenge despite the availability of chemotherapy and BCG vaccine. Drug resistance for all first-line anti-tuberculosis agents and some second-line agents has been observed. Moreover, the occurrence of strains of M. tuberculosis resistant to multiple anti-tuberculosis drugs is increasing. Mechanisms of action and resistance of major anti-tuberculosis drugs are reviewed. In addition, the phenotypic drug resistance such as dormant or persistent tubercle bacilli and its importance are also emphasized. In order to combat the threat of drug resistant tuberculosis and to more effectively control the disease, an understanding of the mechanisms underlying drug resistance is necessary. This knowledge could be used for the development of molecular tests for rapid detection of drug resistant bacilli and future anti-tuberculosis drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据